Описание
Алтернатива на MAGNOIL от Айдеялабс
References:
CNS/mood/cognition
[Molecular mechanisms of pidolate magnesium action and its neurotropic affects]. – PubMed – NCBI
“…RESULTS: Neurotropic effects of magnesium pyroglutamate are due to an influence on the synthesis of neuropeptides containing pyroglutamate (orexin, thyroliberin, neurotensin etc) and due to the similarity between pyroglutamate-anion with some neuroactive components (L-theanine, 2-pirrolydinone, piracetam). CONCLUSION: The results of the study suggest neuroprotective, sedative and antidepressive properties of magnesium pyroglutamate which are realized by pyroglutamate-anion in the synergism with magnesium cation.”
Magnesium as a preventive treatment for paediatric episodic tension-type headache: results at 1-year follow-up. – PubMed – NCBI
Magnesium as a treatment for paediatric tension-type headache: a clinical replication series. – PubMed – NCBI
Visual evoked potentials and serum magnesium levels in juvenile migraine patients. – PubMed – NCBI
Reversible model of magnesium depletion induced by systemic kainic acid injection in magnesium-deficient rats: I–Comparative study of various magn… – PubMed – NCBI
Inhibition of mouse-killing behaviour in magnesium-deficient rats: effect of pharmacological doses of magnesium pidolate, magnesium aspartate, magn… – PubMed – NCBI
[Psychopharmacological properties of three magnesium salts: pidolate, lactate and aspartate]. – PubMed – NCBI
[Magnesium in the prophylaxis of primary headache and other periodic disorders in children]. – PubMed – NCBI
CVD/circulation/blood pressure/anemia
[Effects of magnesium pidolate on cardiovascular hemodynamics]. – PubMed – NCBI
[Effects of magnesium pidolate on cardiovascular hemodynamics]. – PubMed – NCBI
Magnesium for treating sickle cell disease. – PubMed – NCBI
Late outcome of a randomized study on oral magnesium for premature complexes. – PubMed – NCBI
Late Outcome of a Randomized Study on Oral Magnesium for Premature Complexes. – PubMed – NCBI
Successful improvement of frequency and symptoms of premature complexes after oral magnesium administration. – PubMed – NCBI
Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. – PubMed – NCBI
Promising therapies in sickle cell disease. – PubMed – NCBI
Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia. – PubMed – NCBI
[Clinical trials of new therapeutic pharmacology for sickle cell disease]. – PubMed – NCBI
Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease. – PubMed – NCBI
The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia. – PubMed – NCBI
Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. – PubMed – NCBI
Metabolism/diabetes
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. – PubMed – NCBI
Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of met… – PubMed – NCBI
Oral magnesium supplementation improves vascular function in elderly diabetic patients. – PubMed – NCBI
Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. – PubMed – NCBI
[Comparative study of the short-term acceptability and tolerance of a new oral formulation of magnesium (TX 1341) and a reference magnesium]. – PubMed – NCBI
Intravenous and oral magnesium supplementations in the prophylaxis of cisplatin-induced hypomagnesemia. Results of a controlled trial. – PubMed – NCBI
Reproductive
Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea. – PubMed – NCBI
Allergies
Magnesium pidolate in the treatment of seasonal allergic rhinitis. Preliminary data. – PubMed – NCBI
Отзиви
Все още няма отзиви.